35. Breakthrough Status, Collateral Damage
Aired May 15, 201644 min
Scott Pelley follows patients in a Duke clinical trial of a new cancer therapy that the FDA has granted breakthrough status; and, Bill Whitaker reports on how the U.S. fight against Chinese espionage has ensnared innocent Americans.
Your diary entry
Sign in to log when you watched this episode, add your rating, and write a review.
Sign in →